Form 4: Tectonic Therapeutic CFO Acquires Shares in Private Placement
SEC Form 4 Filing
Daniel Lochner, CFO of Tectonic Therapeutic, purchased 4,617 shares of common stock in a private placement transaction.
Summary
- Daniel Lochner, the Chief Financial Officer of Tectonic Therapeutic, Inc. [TECX], acquired 4,617 shares of common stock on February 5, 2025.
- The shares were purchased at a price of $54.14 per share.
- The transaction was part of a private placement previously announced on February 3, 2025, in the Issuer's Current Report on Form 8-K.
- The purchase was made in reliance on the exemption afforded by Regulation D of the Securities Act of 1933.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard regulatory filing related to an insider transaction. The CFO's purchase is a positive sign, but the filing itself is routine.
Positives
- The CFO's investment could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Stakeholder Impact
- The CFO's purchase could increase investor confidence.
Key Dates
| Date | Description |
|---|---|
| 02/03/2025 | Date of the Issuer's Current Report on Form 8-K announcing the private placement. |
| 02/05/2025 | Date of the transaction where Daniel Lochner acquired shares. |
| 02/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.